Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/5/2020
SIETES contiene 93013 citas

 
 
<< anterior 21 a 40 de 202 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin–angiotensin–aldosterone system blockers and the risk of covid-19. N Engl J Med 2020:1 de mayo. [Ref.ID 103603]
22.Tiene citas relacionadas Cita con resumen
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in covid-19. N Engl J Med 2020:1 de mayo. [Ref.ID 103602]
23. Cita con resumen
Iacobucci G. Sixty seconds on . . . the RECOVERY trial. BMJ 2020;369:20 de abril. [Ref.ID 103597]
24. Cita con resumen
Gandhi RT, Lynch JB, Del Río C. Mild or moderate Covid-19. N Engl J Med 2020:1. [Ref.ID 103596]
25.Enlace a cita original Cita con resumen
Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. BMJ 2020;369:8 de abril. [Ref.ID 103595]
26. Cita con resumen
Zhang PZhi L, Cai J, Lei F, Qin J-J, Xie J, Liu Y-M, Zhao Y-C, Huang X, Lin L, Xia M, Chen M-M, Cheng X, Zhang X, Guo D, Peng Y, Ji Y-X, Chen J, She Z-G, Wang Y, Xu Q, Tan R, Wang H, Lin J, Luo P, Fu S, Cai H, Ye P, Xiao B, et al.. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation Research 2020:17 de abril. [Ref.ID 103594]
30. Cita con resumen
31. Cita con resumen
Little P. Non-steroidal anti-inflammatory drugs and covid-19. BMJ 2020;368:27 de marzo. [Ref.ID 103583]
32. Cita con resumen
Barnett ML. Opioid prescribing in the midst of crisis — Myths and realities. N Engl J Med 2020;382:19 de marzo. [Ref.ID 103579]
33. Cita con resumen
Anónimo. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. U.S. Food and Drug Administration 2020:19 de marzo. [Ref.ID 103572]
35. Cita con resumen
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. Lancet Respiratory Medicine 2020:11 de marzo. [Ref.ID 103569]
36.Enlace a cita original Cita con resumen
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, et al.. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020:18 de marzo. [Ref.ID 103564]
38.Enlace a cita original Cita con resumen
Walsh LK, Donelle J, Dodds L, Hawken S, Wilson K, Benchimol EI, Chakraborty P, Guttmann A, Kwong JC, MacDonald NE, Sprague AE, Top KA, Walker MC, Web SW, Fell DB. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. BMJ 2019;366:10 de julio. [Ref.ID 103171]
39.Enlace a cita original Cita con resumen
Dommasch ED, Kim SC, Lee MP, Gagne JJ. Risk of serious infection in patients receiving systemic medications for the treatment of psoriasis. JAMA Dermatol 2019:10 de mayo. [Ref.ID 103131]
Seleccionar todas
 
<< anterior 21 a 40 de 202 siguiente >>